$ASMB
Assembly Biosciences Inc

2014 Q4 Form 10-Q Financial Statement

#000114420414069040 Filed on November 17, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.310M $7.380M $12.33M
YoY Change -73.15% 525.42% 1041.67%
% of Gross Profit
Research & Development $2.980M $3.672M -$140.0K
YoY Change -2228.57% -2.17% -105.11%
% of Gross Profit
Depreciation & Amortization $10.00K $1.602K $10.00K
YoY Change 0.0%
% of Gross Profit
Operating Expenses $6.280M $3.672M $12.19M
YoY Change -48.48% -2.17% 219.11%
Operating Profit -$11.06M
YoY Change 124.11%
Interest Expense $60.00K $40.00K $50.00K
YoY Change 20.0% -20.0% 66.67%
% of Operating Profit
Other Income/Expense, Net $35.18K
YoY Change -31.37%
Pretax Income -$6.230M -$11.02M -$12.14M
YoY Change -48.68% 125.82% 220.32%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$6.230M -$11.02M -$12.14M
YoY Change -48.68% 125.74% 220.22%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$590.5K -$1.331M -$2.911M
COMMON SHARES
Basic Shares Outstanding 10.65M shares 8.688M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $29.10M $17.90M $27.10M
YoY Change 7.38% -44.41% 32.2%
Cash & Equivalents $29.09M $17.93M $27.06M
Short-Term Investments
Other Short-Term Assets $125.3K $147.2K $63.67K
YoY Change 96.76% 9.2% 6.86%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $29.22M $18.08M $27.12M
YoY Change 7.71% -44.13% 32.0%
LONG-TERM ASSETS
Property, Plant & Equipment $156.4K $34.08K $7.102K
YoY Change 2102.77% 346.59% 3.82%
Goodwill $12.74M $12.64M $0.00
YoY Change
Intangibles $29.00M $30.14M $0.00
YoY Change
Long-Term Investments $100.0K $0.00
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $42.01M $42.31M $7.102K
YoY Change 591406.56% 554330.5% 3.82%
TOTAL ASSETS
Total Short-Term Assets $29.22M $18.08M $27.12M
Total Long-Term Assets $42.01M $42.31M $7.102K
Total Assets $71.23M $60.39M $27.13M
YoY Change 162.51% 86.6% 31.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $900.0K $1.000M $2.615M
YoY Change -65.58% -56.15% 41.54%
Accrued Expenses $146.4K $23.44K
YoY Change 524.79% -97.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.054M $1.049M $2.638M
YoY Change -60.05% -54.39% -2.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $11.60M $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.054M $1.049M $2.638M
Total Long-Term Liabilities $11.60M $0.00 $0.00
Total Liabilities $12.65M $13.19M $2.638M
YoY Change 379.67% 469.18% -3.91%
SHAREHOLDERS EQUITY
Retained Earnings -$135.5M -$129.3M -$111.7M
YoY Change 21.29%
Common Stock $10.67K $4.147K
YoY Change 157.34% -67.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $58.57M $47.20M $24.49M
YoY Change
Total Liabilities & Shareholders Equity $71.23M $60.39M $27.13M
YoY Change 162.51% 86.6% 31.99%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q4
OPERATING ACTIVITIES
Net Income -$6.230M -$11.02M -$12.14M
YoY Change -48.68% 125.74% 220.22%
Depreciation, Depletion And Amortization $10.00K $1.602K $10.00K
YoY Change 0.0%
Cash From Operating Activities -$3.590M -$3.870M -$5.400M
YoY Change -33.52% -16.77% 75.9%
INVESTING ACTIVITIES
Capital Expenditures -$130.0K -$20.00K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$80.00K $510.0K
YoY Change
Cash From Investing Activities -$210.0K $490.0K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $15.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 14.97M 0.000 230.0K
YoY Change 6408.7% -100.0%
NET CHANGE
Cash From Operating Activities -3.590M -3.870M -5.400M
Cash From Investing Activities -210.0K 490.0K 0.000
Cash From Financing Activities 14.97M 0.000 230.0K
Net Change In Cash 11.17M -3.380M -5.170M
YoY Change -316.05% 168.25% 68.4%
FREE CASH FLOW
Cash From Operating Activities -$3.590M -$3.870M -$5.400M
Capital Expenditures -$130.0K -$20.00K $0.00
Free Cash Flow -$3.460M -$3.850M -$5.400M
YoY Change -35.93% -17.2% 75.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11380582 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15003740 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17932627 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27061268 USD
CY2014Q3 us-gaap Other Assets Current
OtherAssetsCurrent
147178 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
63672 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
18079805 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
27124940 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34084 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7102 USD
CY2014Q3 us-gaap Assets
Assets
60393941 USD
CY2013Q4 us-gaap Assets
Assets
27132042 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
44 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
4147 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
135844320 USD
CY2014Q3 asmb Common Stock Value Issuable
CommonStockValueIssuable
368750 USD
CY2013Q4 asmb Common Stock Value Issuable
CommonStockValueIssuable
368750 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-129282721 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-111723273 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
47202220 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
24493988 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60393941 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27132042 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
75000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
0 shares
CY2013Q4 asmb Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
10.20
CY2014Q3 asmb Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
0
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
172209 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
467698 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2682700 shares
us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
572398 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3199651 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.35
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.74
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
27.22
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.27
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6245656 USD
CY2014Q3 asmb Future Stock Based Compensation Expense Year Two
FutureStockBasedCompensationExpenseYearTwo
6040120 USD
CY2014Q3 asmb Future Stock Based Compensation Expense Year Three
FutureStockBasedCompensationExpenseYearThree
1595568 USD
CY2014Q3 asmb Future Stock Based Compensation Expense Total
FutureStockBasedCompensationExpenseTotal
10007300 USD
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8688099 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4146779 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8688099 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4146779 shares
CY2014Q3 asmb Common Stock Issuable Shares
CommonStockIssuableShares
25000 shares
CY2013Q4 asmb Common Stock Issuable Shares
CommonStockIssuableShares
25000 shares
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9870871 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7741317 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3753319 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3671983 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3639863 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9930418 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1179689 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7383457 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-13510734 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-17671735 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4933008 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11055440 USD
us-gaap Net Income Loss
NetIncomeLoss
-13356725 USD
us-gaap Net Income Loss
NetIncomeLoss
-17559448 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-4881742 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-11020258 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.53
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.02
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.23
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.33
us-gaap Share Based Compensation
ShareBasedCompensation
1451688 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8002033 USD
us-gaap Depreciation
Depreciation
4375 USD
us-gaap Depreciation
Depreciation
3894 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
75196 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-427798 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2463148 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12403656 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5166 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20526 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5166 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
488837 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
24142513 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
1763104 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24142513 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1763104 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
11733691 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9128641 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20489219 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32222910 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
154009 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
43360 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
112287 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
51266 USD
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10647059 shares
CY2014Q3 asmb Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwill
12142702 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
35182 USD
CY2014Q3 us-gaap Goodwill
Goodwill
12142702 USD
CY2013Q4 us-gaap Goodwill
Goodwill
0 USD
CY2014Q3 us-gaap Liabilities
Liabilities
13191721 USD
CY2013Q4 us-gaap Liabilities
Liabilities
2638054 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
509363 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
40146 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
10350 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
30137350 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
42839911 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
12142702 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
29823096 USD
CY2014Q3 asmb Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Expenses
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses
874113 USD
CY2014Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
4008848 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
621651 shares
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
12142702 USD
CY2014Q3 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
29823096 USD
CY2014Q3 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
12142702 USD
CY2013Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0 USD
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
ASSEMBLY BIOSCIENCES, INC.
dei Entity Central Index Key
EntityCentralIndexKey
0001426800
CY2014Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
30137350 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
271501 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
120265 shares
asmb Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodTotalIntrinsicValue
2534400 USD
asmb Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodTotalIntrinsicValue
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
75000 shares
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
38.85
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.13
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
24.37
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
ASMB
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
514445 shares
CY2014Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2560000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.20
CY2014Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
120265 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y8M12D
CY2014Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
The Companys Board of Directors and stockholders approved a 1-for-5 reverse stock split of the Companys common stock.
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2638054 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-509363 USD
asmb Noncash Or Part Noncash Acquisition Other Current Assets
NoncashOrPartNoncashAcquisitionOtherCurrentAssets
0 USD
asmb Noncash Or Part Noncash Acquisition Other Current Assets
NoncashOrPartNoncashAcquisitionOtherCurrentAssets
40146 USD
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
30137350 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1048087 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.42
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1891627 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1049019 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
10350 USD
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
30137350 USD
asmb Noncash Or Part Noncash Acquisition Other Current Goodwill
NoncashOrPartNoncashAcquisitionOtherCurrentGoodwill
0 USD
asmb Noncash Or Part Noncash Acquisition Other Current Goodwill
NoncashOrPartNoncashAcquisitionOtherCurrentGoodwill
12142702 USD
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
874113 USD
asmb Noncash Or Part Noncash Acquisition Share Exchange Business Combination
NoncashOrPartNoncashAcquisitionShareExchangeBusinessCombination
29064148 USD
asmb Noncash Or Part Noncash Acquisition Fair Value Of Vested Options And Restricted Stock
NoncashOrPartNoncashAcquisitionFairValueOfVestedOptionsAndRestrictedStock
0 USD
asmb Noncash Or Part Noncash Acquisition Fair Value Of Vested Options And Restricted Stock
NoncashOrPartNoncashAcquisitionFairValueOfVestedOptionsAndRestrictedStock
758948 USD
asmb Noncash Or Part Noncash Acquisition Deferred Tax Liability
NoncashOrPartNoncashAcquisitionDeferredTaxLiability
0 USD
asmb Noncash Or Part Noncash Acquisition Deferred Tax Liability
NoncashOrPartNoncashAcquisitionDeferredTaxLiability
12142702 USD
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
0 USD
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
509363 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
440 USD
CY2014Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1049019 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2638054 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
679447 USD
us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
30137350 USD
asmb Share Based Compensation Arrangement By Share Based Payment Award Options Assumed
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumed
621651 shares
asmb Share Based Compensation Arrangement By Share Based Payment Award Options Assumed Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedWeightedAverageExercisePrice
2.22
asmb Share Based Compensation Arrangement By Share Based Payment Award Options Assumed Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedAggregateIntrinsicValue
3711256 USD
CY2014Q3 asmb Future Stock Based Compensation Expense Remainder Of Fiscal Year
FutureStockBasedCompensationExpenseRemainderOfFiscalYear
2371612 USD
CY2014Q3 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
12142702 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
0 USD
CY2014Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
13016815 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
13510734 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
17671735 USD
CY2013Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4933008 USD
CY2014Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
11055440 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3780343 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5814316 shares
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3978905 shares
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8277355 shares
us-gaap Interest Income Other
InterestIncomeOther
154009 USD
us-gaap Interest Income Other
InterestIncomeOther
112287 USD
CY2013Q3 us-gaap Interest Income Other
InterestIncomeOther
51266 USD
CY2014Q3 us-gaap Interest Income Other
InterestIncomeOther
35182 USD
us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
1763104 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
29064148 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
us-gaap Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
758948 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
679447 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8002033 USD
asmb Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expired In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod
20973 shares
CY2014Q3 asmb Share Based Compensation Arrangement By Share Based Payment Award Equity Instrumen Ts Other Than Options Exercisable In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumenTsOtherThanOptionsExercisableInPeriod
271501 shares
asmb Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expired In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriodWeightedAverageGrantDateFairValue
33.00
CY2014Q3 asmb Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
24.37
CY2014Q3 asmb Noncash Or Part Noncash Acquisition Fair Value Of Vested Options And Restricted Stock
NoncashOrPartNoncashAcquisitionFairValueOfVestedOptionsAndRestrictedStock
758948 USD
CY2014Q3 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
0 USD
asmb Share Based Compensation Arrangement By Share Based Payment Award Equity Non Option Forfeited Weighted Average Grant Date Fairvalue
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityNonOptionForfeitedWeightedAverageGrantDateFairvalue
10.20
CY2014Q3 asmb Noncash Or Part Noncash Acquisition Share Exchange Business Combination
NoncashOrPartNoncashAcquisitionShareExchangeBusinessCombination
29064148 USD
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
57953 shares
CY2014Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 USD
CY2014Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 USD
CY2014Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
6752089 USD

Files In Submission

Name View Source Status
0001144204-14-069040-index-headers.html Edgar Link pending
0001144204-14-069040-index.html Edgar Link pending
0001144204-14-069040.txt Edgar Link pending
0001144204-14-069040-xbrl.zip Edgar Link pending
asmb-20140930.xml Edgar Link completed
asmb-20140930.xsd Edgar Link pending
asmb-20140930_cal.xml Edgar Link unprocessable
asmb-20140930_def.xml Edgar Link unprocessable
asmb-20140930_lab.xml Edgar Link unprocessable
asmb-20140930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v393386_10q.htm Edgar Link pending
v393386_ex10-29.htm Edgar Link pending
v393386_ex31-1.htm Edgar Link pending
v393386_ex31-2.htm Edgar Link pending
v393386_ex32-1.htm Edgar Link pending
v393386_ex32-2.htm Edgar Link pending